Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients

Daniella Klebaner; Stephen Hamilton-Dutoit; Thomas Ahern; Anatasha Crawford; Thomas Jakobsen; Deirdre P. Cronin-Fenton; Per Damkier; Emiel Janssen; Anders Kjaersgaard; Anne Gulbech Ording; Håvard Søiland; Henrik Toft Sørensen; Timothy L. Lash; Ylva Hellberg

doi:10.1371/journal.pone.0171453

Loading metrics

Open Access

Peer-reviewed

Research Article

Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients

Daniella Klebaner,

Affiliation Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America

http://orcid.org/0000-0003-2523-4164

⨯
Stephen Hamilton-Dutoit,

Affiliation Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark
⨯
Thomas Ahern,

Affiliation Departments of Surgery and Biochemistry, University of Vermont College of Medicine, Burlington, Vermont, United States of America
⨯
Anatasha Crawford,

Affiliation Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America
⨯
Thomas Jakobsen,

Affiliation Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark
⨯
Deirdre P. Cronin-Fenton,

Affiliation Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark
⨯
Per Damkier,

Affiliation Department of Clinical Chemistry & Pharmacology, Odense University Hospital, Odense, Denmark
⨯
Emiel Janssen,

Affiliation Department of Pathology, Stavanger University Hospital, Stavanger, Norway
⨯
Anders Kjaersgaard,

Affiliation Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark
⨯
Anne Gulbech Ording,

Affiliation Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark
⨯
Håvard Søiland,

Affiliations Department of Breast and Endocrine Surgery, Stavanger University Hospital, Stavanger, Norway, Department of Clinical Science, University of Bergen, Bergen, Norway
⨯
Henrik Toft Sørensen,

Affiliation Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark
⨯
Timothy L. Lash ,

* E-mail: Tlash@emory.edu

Affiliations Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America, Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark
⨯
Ylva Hellberg

Affiliation Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark
⨯

Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients

Daniella Klebaner,
Stephen Hamilton-Dutoit,
Thomas Ahern,
Anatasha Crawford,
Thomas Jakobsen,
Deirdre P. Cronin-Fenton,
Per Damkier,
Emiel Janssen,
Anders Kjaersgaard,
Anne Gulbech Ording

Published: March 16, 2017
https://doi.org/10.1371/journal.pone.0171453

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Cancer detection and diagnosis
Is the Subject Area "Cancer detection and diagnosis" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cytoplasmic staining
Is the Subject Area "Cytoplasmic staining" applicable to this article?

Thanks for your feedback.
Nuclear staining
Is the Subject Area "Nuclear staining" applicable to this article?

Thanks for your feedback.
Apolipoproteins
Is the Subject Area "Apolipoproteins" applicable to this article?

Thanks for your feedback.
Hormonal therapy
Is the Subject Area "Hormonal therapy" applicable to this article?

Thanks for your feedback.
Estrogens
Is the Subject Area "Estrogens" applicable to this article?

Thanks for your feedback.